156 results on '"Handanagic, Senad"'
Search Results
2. Trends in new hepatitis C virus infections among repeat blood donors – Georgia, 2017–2023
3. Receptive anal sex contributes substantially to heterosexually acquired HIV infections among at‐risk women in twenty US cities: Results from a modelling analysis
4. Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs—Cabell County, West Virginia, 2019
5. HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs — 23 Metropolitan Statistical Areas, United States, 2018
6. Association Between Dual Partnership and Sexual and Injecting Behaviors Among Persons Who Inject Drugs in 23 US Cities, 2018
7. Evaluation of Knowledge, Attitudes and Practices for Hepatitis B Virus Infection Among Primary Healthcare Physicians in Georgia.
8. WED-484 Hepatitis C virus and HIV infection among persons who inject drugs in six sites in Tajikistan, 2022
9. Mass Testing for SARS-CoV-2 in 16 Prisons and Jails — Six Jurisdictions, United States, April–May 2020
10. COVID-19 in Correctional and Detention Facilities — United States, February–April 2020
11. Outbreak of Human Immunodeficiency Virus Infection Among Persons Who Inject Drugs — Cabell County, West Virginia, 2018–2019
12. Syringe Services Programs’ Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them
13. Response to a Large HIV Outbreak, Cabell County, West Virginia, 2018–2019
14. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019
15. Racial, Ethnic, Sex, and Age Differences in COVID-19 Cases, Hospitalizations, and Deaths Among Incarcerated People and Staff in Correctional Facilities in Six Jurisdictions, United States, March-July 2020.
16. Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States.
17. Hepatitis B and hepatitis C testing practices and observed seroconversions among dialysis facilities in Georgia.
18. Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015
19. Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities—National HIV Behavioral Surveillance, 2018
20. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
21. Overdose mortality rates in Croatia and factors associated with self-reported drug overdose among persons who inject drugs in three Croatian cities
22. Lessons Learned From Global Hepatitis C Elimination Programs.
23. HIV Prevalence Among Women Who Exchange Sex for Money or Drugs—4 U.S. Cities
24. Racial, Ethnic, Sex, and Age Differences in COVID-19 Cases, Hospitalizations, and Deaths Among Incarcerated People and Staff in Correctional Facilities in Six Jurisdictions, United States, March-July 2020
25. Insights from a national survey in 2021 and from modelling on progress towards hepatitis C virus elimination in the country of Georgia since 2015
26. Characterizing individuals who remain to be screened and those lost to follow-up from Georgia’s HCV elimination program
27. Progress in hepatitis C screening as part of the hepatitis C elimination program in Georgia
28. Spontaneous clearance of hepatitis C virus infection in the country of Georgia, 2015–2021
29. Hepatitis C seroconversion rates among individuals with repeated testing-Georgia, 2017–2021
30. Who is missing? Analysis of the 2021 Georgian seroprevalence survey to identify the population left to be screened for hepatitis C
31. Implementing hepatitis C self-testing (HCVST) among the general population in Georgia: preliminary results
32. Factors associated with HCV reinfection among treated people who inject drugs in the HCV elimination program in Georgia
33. Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-December 2022
34. Late presentation of chronic hepatitis C for care in Georgia: data from the national hepatitis C elimination program, 2016–2021
35. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys
36. Nonprescription Hormone Use Among Transgender Women -- National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020.
37. Nationwide hepatitis C serosurvey and progress towards HCV elimination in the country of Georgia, 2021
38. Latent Classes of Sexual Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Among Women Who Inject Drugs Across 20 US Cities
39. Nationwide Hepatitis C Serosurvey and Progress Towards Hepatitis C Virus Elimination in the Country of Georgia, 2021.
40. HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs--23 Metropolitan Statistical Areas, United States, 2018
41. Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017
42. Estimated Number of People Who Inject Drugs in the United States
43. Progress in HCV screening in the national hepatitis C elimination program in Georgia during the COVID-19 pandemic, 2019–2021
44. Epidemiology of hepatitis B virus infection among hepatitis C (HCV) infected patients treated within HCV elimination program in Georgia
45. Progress towards HCV elimination in the country of Georgia: insights from modelling and national survey
46. Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017.
47. Estimated Number of People Who Inject Drugs in the United States.
48. Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs—Cabell County, West Virginia, 2019
49. THU-214 - Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-December 2022
50. FRI-203 - Factors associated with HCV reinfection among treated people who inject drugs in the HCV elimination program in Georgia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.